These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 25634026)
1. Influence of reproductive history and exogenous hormone use on prevalence and frequency of circulating t(14;18)-positive cells in a population-based cross-sectional study. Weitmann K; Hirt C; Schwarz S; Rabkin C; Dölken G; Hoffmann W Cancer Causes Control; 2015 Mar; 26(3):455-65. PubMed ID: 25634026 [TBL] [Abstract][Full Text] [Related]
2. Oral contraceptives, menopausal hormone therapy use and risk of B-cell non-Hodgkin lymphoma in the California Teachers Study. Lu Y; Wang SS; Sullivan-Halley J; Chang ET; Clarke CA; Henderson KD; Ma H; Duan L; Lacey JV; Deapen D; Bernstein L Int J Cancer; 2011 Aug; 129(4):974-82. PubMed ID: 20957632 [TBL] [Abstract][Full Text] [Related]
3. Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies. Zhong GC; Liu Y; Chen N; Hao FB; Wang K; Cheng JH; Gong JP; Ding X Hum Reprod Update; 2016 Dec; 23(1):126-138. PubMed ID: 27655589 [TBL] [Abstract][Full Text] [Related]
4. Menopausal hormone therapy and gallbladder disease: the Study of Health in Pomerania (SHIP). Schwarz S; Völzke H; Baumeister SE; Hampe J; Dören M Clin Endocrinol (Oxf); 2007 Jul; 67(1):51-9. PubMed ID: 17437513 [TBL] [Abstract][Full Text] [Related]
5. Association between menopausal hormone therapy and the risk of gastric cancer: A Korean nationwide population-based cohort study. Han KH; Choi YJ; Han K; Shin CM; Park NH; Lee DH Maturitas; 2024 Jun; 184():107960. PubMed ID: 38460415 [TBL] [Abstract][Full Text] [Related]
6. Oral Contraceptive and Menopausal Hormone Therapy Use and Risk of Pituitary Adenoma: Cohort and Case-Control Analyses. Cote DJ; Kilgallon JL; Nawabi NLA; Dawood HY; Smith TR; Kaiser UB; Laws ER; Manson JE; Stampfer MJ J Clin Endocrinol Metab; 2022 Mar; 107(4):e1402-e1412. PubMed ID: 34865056 [TBL] [Abstract][Full Text] [Related]
7. Gynaecological health care utilization and use of sex hormones--the study of Health in Pomerania. Schwarz S; Völzke H; Alte D; Hoffmann W; John U; Dören M Hum Reprod; 2005 Oct; 20(10):2916-22. PubMed ID: 15980010 [TBL] [Abstract][Full Text] [Related]
8. Female Estrogen-Related Factors and Incidence of Basal Cell Carcinoma in a Nationwide US Cohort. Cahoon EK; Kitahara CM; Ntowe E; Bowen EM; Doody MM; Alexander BH; Lee T; Little MP; Linet MS; Freedman DM J Clin Oncol; 2015 Dec; 33(34):4058-65. PubMed ID: 26527779 [TBL] [Abstract][Full Text] [Related]
9. Menopausal hormone therapy and the risk of esophageal and gastric cancer. Brusselaers N; Maret-Ouda J; Konings P; El-Serag HB; Lagergren J Int J Cancer; 2017 Apr; 140(7):1693-1699. PubMed ID: 28006838 [TBL] [Abstract][Full Text] [Related]
10. Use of Menopausal Hormone Therapy and Bioidentical Hormone Therapy in Australian Women 50 to 69 Years of Age: Results from a National, Cross-Sectional Study. Velentzis LS; Banks E; Sitas F; Salagame U; Tan EH; Canfell K PLoS One; 2016; 11(3):e0146494. PubMed ID: 27008039 [TBL] [Abstract][Full Text] [Related]
11. Non-Hodgkin lymphoma in women: reproductive factors and exogenous hormone use. Lee JS; Bracci PM; Holly EA Am J Epidemiol; 2008 Aug; 168(3):278-88. PubMed ID: 18550561 [TBL] [Abstract][Full Text] [Related]
12. A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones. La Vecchia C; Ron E; Franceschi S; Dal Maso L; Mark SD; Chatenoud L; Braga C; Preston-Martin S; McTiernan A; Kolonel L; Mabuchi K; Jin F; Wingren G; Galanti MR; Hallquist A; Lund E; Levi F; Linos D; Negri E Cancer Causes Control; 1999 Apr; 10(2):157-66. PubMed ID: 10231164 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of osteoporosis and its reproductive risk factors among Jordanian women: a cross-sectional study. Shilbayeh S Osteoporos Int; 2003 Nov; 14(11):929-40. PubMed ID: 14530908 [TBL] [Abstract][Full Text] [Related]
14. Oral contraceptive use and risk of colorectal cancer. Fernandez E; La Vecchia C; Franceschi S; Braga C; Talamini R; Negri E; Parazzini F Epidemiology; 1998 May; 9(3):295-300. PubMed ID: 9583422 [TBL] [Abstract][Full Text] [Related]
15. Association between menopausal hormone therapy, mammographic density and breast cancer risk: results from the E3N cohort study. Fornili M; Perduca V; Fournier A; Jérolon A; Boutron-Ruault MC; Maskarinec G; Severi G; Baglietto L Breast Cancer Res; 2021 Apr; 23(1):47. PubMed ID: 33865453 [TBL] [Abstract][Full Text] [Related]
16. Menopausal hormone therapy, oral contraceptives and risk of chronic low back pain: the HUNT Study. Heuch I; Heuch I; Hagen K; Storheim K; Zwart JA BMC Musculoskelet Disord; 2023 Jan; 24(1):84. PubMed ID: 36721124 [TBL] [Abstract][Full Text] [Related]
17. Menopausal hormone therapy: Characterising users in an Australian national cross-sectional study. Velentzis LS; Egger S; Banks E; Canfell K PLoS One; 2021; 16(8):e0253725. PubMed ID: 34379634 [TBL] [Abstract][Full Text] [Related]
18. Differences in menopausal hormone therapy use among women in Germany between 1998 and 2003. Du Y; Dören M; Melchert HU; Scheidt-Nave C; Knopf H BMC Womens Health; 2007 Oct; 7():19. PubMed ID: 17945013 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of offering menopause hormone therapy among primary care doctors and its associated factors: A cross-sectional study. Low TL; Cheong AT; Devaraj NK; Ismail R PLoS One; 2024; 19(9):e0310994. PubMed ID: 39321159 [TBL] [Abstract][Full Text] [Related]
20. Inverse associations of dietary fiber and menopausal hormone therapy with colorectal cancer risk in the Multiethnic Cohort Study. Park SY; Wilkens LR; Kolonel LN; Henderson BE; Le Marchand L Int J Cancer; 2016 Sep; 139(6):1241-50. PubMed ID: 27137137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]